{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:02:37Z","timestamp":1790650957134,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.4158\/ep171761.ra","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T10:07:35Z","timestamp":1495534055000},"page":"989-998","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"title":["Biotin Interference with Routine Clinical Immunoassays: Understand the Causes and Mitigate the Risks"],"prefix":"10.1016","volume":"23","author":[{"given":"Shanika","family":"Samarasinghe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Meah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinita","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshi","family":"Basit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Emanuele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ann","family":"Emanuele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaleh","family":"Mazhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Earle W.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP171761.RA_bb0010","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1586\/17446651.3.6.715","article-title":"Biotin and biotinidase deficiency","volume":"3","author":"Zempleni","year":"2008","journal-title":"Expert Rev Endocrinol Metab"},{"key":"10.4158\/EP171761.RA_bb0015","series-title":"Modern Nutrition in Health and Disease","first-page":"459","article-title":"Biotin","author":"Mock","year":"2000"},{"key":"10.4158\/EP171761.RA_bb0020","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/clinchem\/37.5.625","article-title":"The biotin-(strept) avidin system: principles and applications in biotechnology","volume":"37","author":"Diamandis","year":"1991","journal-title":"Clin Chem"},{"key":"10.4158\/EP171761.RA_bb0025","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0076-6879(90)84308-4","article-title":"Avidin-biotin mediated immunoassays: overview","volume":"184","author":"Wil\u0107hek","year":"1990","journal-title":"Methods Enzymol"},{"key":"10.4158\/EP171761.RA_bb0030","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1056\/NEJMc1602096","article-title":"Biotin Treatment Mimicking Graves' Disease","volume":"375","author":"Kummer","year":"2016","journal-title":"N Engl J Med"},{"key":"10.4158\/EP171761.RA_bb0035","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.msard.2015.01.005","article-title":"High doses of biotin in chronic progressive multiple sclerosis: a pilot study","volume":"4","author":"Sedel","year":"2015","journal-title":"Mult Scler Relat Disord"},{"key":"10.4158\/EP171761.RA_bb0040","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1620\/tjem.227.217","article-title":"Biotin ameliorates muscle cramps of hemodialysis patients: a prospective trial","volume":"227","author":"Oguma","year":"2012","journal-title":"Tohoku J Exp Med"},{"key":"10.4158\/EP171761.RA_bb0045","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4158\/EP12158.OR","article-title":"Falsely low parathyroid hormone secondary to biotin interference: a case series","volume":"19","author":"Waghray","year":"2013","journal-title":"Endocr Pract"},{"key":"10.4158\/EP171761.RA_bb0050","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/biof.8","article-title":"Biotin","volume":"35","author":"Zempleni","year":"2009","journal-title":"BioFactors"},{"key":"10.4158\/EP171761.RA_bb0055","series-title":"The National Academies","article-title":"Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline","author":"Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate OBV, and Choline","year":"1998"},{"key":"10.4158\/EP171761.RA_bb0060","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1210\/jc.2016-1971","article-title":"Factitious Graves' Disease Due to Biotin Immunoassay Interference-A Case and Review of the Literature","volume":"101","author":"Elston","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP171761.RA_bb0065","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3390\/nu8020068","article-title":"B Vitamins and the Brain: Mechanisms, Dose and Efficacy--A Review","volume":"8","author":"Kennedy","year":"2016","journal-title":"Nutrients"},{"key":"10.4158\/EP171761.RA_bb0070","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/PAT.0b013e3283514002","article-title":"Biotin interference on TSH and free thyroid hormone measurement","volume":"44","author":"Kwok","year":"2012","journal-title":"Pathology"},{"key":"10.4158\/EP171761.RA_bb0075","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jnutbio.2012.03.020","article-title":"Effects of biotin supplementation in the diet on insulin secretion, islet gene expression, glucose homeostasis and beta-cell proportion","volume":"24","author":"Lazo de la Vega-Monroy","year":"2013","journal-title":"J Nutr Biochem"},{"key":"10.4158\/EP171761.RA_bb0080","series-title":"Present knowledge in nutrition","article-title":"Biotin","author":"Zempleni","year":"2012"},{"key":"10.4158\/EP171761.RA_bb0085","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0955-2863(98)00095-3","article-title":"Biotin biochemistry and human requirements","volume":"10","author":"Zempleni","year":"1999","journal-title":"J Nutr Biochem"},{"key":"10.4158\/EP171761.RA_bb0090","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1172\/JCI0213138","article-title":"Biotin dependency due to a defect in biotin transport","volume":"109","author":"Mardach","year":"2002","journal-title":"J Clin Invest"},{"key":"10.4158\/EP171761.RA_bb0095","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1517\/17425255.2016.1136288","article-title":"Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis","volume":"12","author":"Peyro Saint Paul","year":"2016","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.4158\/EP171761.RA_bb0100","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/PAT.0b013e32835a3c17","article-title":"Positive and negative interference in immunoassays following biotin ingestion: a pharmacokinetic study","volume":"44","author":"Wijeratne","year":"2012","journal-title":"Pathology"},{"key":"10.4158\/EP171761.RA_bb0105","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/000456329603300214","article-title":"Interference by biotin therapy on measurement of TSH and FT4 by enzyme immunoassay on Boehringer Mannheim ES700 analyser","volume":"33","author":"Henry","year":"1996","journal-title":"Ann Clin Biochem"},{"key":"10.4158\/EP171761.RA_bb0110","unstructured":"KatzmanBMCR, HendrixBK, BlockDR, BaumannNA.Investigation of Biotin Interference in common thyroid function tests using the Roche Elecsys\u00ae immunoassay system. In: Program of the 68th AACC Annual Scientific Meeting & Clinical Lab Expo; July 31\u2013August 4, 2016. Philadelphia, PA. Abstract #A-260."},{"key":"10.4158\/EP171761.RA_bb0115","unstructured":"PerjarIMG, Hammett-StablerCA.Identification of biotin interference with selected VITROS biotin-streptavidin-based immunoassays in individuals taking supplements. In: Program of the 68th AACC Annual Scientific Meeting & Clinical Lab Expo; July 31\u2013August 4, 2016. Philadelphia, PA. Abstract #A-272."},{"key":"10.4158\/EP171761.RA_bb0120","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1056\/NEJMc1611875","article-title":"More on Biotin Treatment Mimicking Graves' Disease","volume":"375","author":"Trambas","year":"2016","journal-title":"N Engl J Med"},{"key":"10.4158\/EP171761.RA_bb0125","unstructured":"PaxtonA.Beauty Fad's Ugly Downside: Test Interference. Available at: http:\/\/www.captodayonline.com\/beauty-fads-ugly-downsidetest-interference\/. Accessed October 2, 2016."},{"key":"10.4158\/EP171761.RA_bb0130","first-page":"23","article-title":"Falsely low parathyroid hormone levels in dialysis patients receiving biotin supplements","author":"Wadhwa","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.4158\/EP171761.RA_bb0135","unstructured":"Siemens Healthcare DiagnosticsI.Customer Bulletin 078D1052-01 Rev. A. Siemens Advia Centaur\u00ae XP: Availability of an Enhanced Intact PTH (iPTH) Assay (US) 2011."},{"key":"10.4158\/EP171761.RA_bb0140","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1515\/cclm-2016-1183","article-title":"High-dose biotin therapy leading to false biochemical endocrine profiles: validation of a simple method to overcome biotin interference","volume":"55","author":"Piketty","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"10.4158\/EP171761.RA_bb0145","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1089\/thy.2015.0664","article-title":"Misdiagnosis of Graves' Disease with Apparent Severe Hyperthyroidism in a Patient Taking Biotin Megadoses","volume":"26","author":"Barbesino","year":"2016","journal-title":"Thyroid"},{"key":"10.4158\/EP171761.RA_bb0150","first-page":"e370","article-title":"High-Dose Biotin Treatment for Secondary Progressive Multiple Sclerosis May Interfere with Thyroid Assays","volume":"2","author":"Minkovsky","year":"2016","journal-title":"AACE Clin Case Rep"},{"key":"10.4158\/EP171761.RA_bb0155","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1515\/cclm-2016-0628","article-title":"Biotin interference in immunoassays mimicking subclinical Graves' disease and hyperestrogenism: a case series","volume":"55","author":"Batista","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"10.4158\/EP171761.RA_bb0160","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.neurol.2017.02.009","article-title":"Biotin in multiple sclerosis and false biological hyperthyroidism: Mind the interference","volume":"173","author":"Willeman","year":"2017","journal-title":"Rev Neurol (Paris)"},{"key":"10.4158\/EP171761.RA_bb0165","unstructured":"BrennanJR, LeeS.High-dose biotin supplement can interfere with common laboratory tests. Available at: http:\/\/www.healio.com\/endocrinology\/thyroid\/news\/print\/endocrine-today\/%7B0ff7371d-93a3-4865-b502-60fde9c98122%7D\/high-dose-biotin-supplement-can-interfere-with-common-laboratory-tests."},{"key":"10.4158\/EP171761.RA_bb0170","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1373\/clinchem.2008.121921","article-title":"A case of renal osteodystrophy with unexpected serum intact parathyroid hormone concentrations","volume":"55","author":"Meany","year":"2009","journal-title":"Clin Chem"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20358456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20358456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:04:06Z","timestamp":1761516246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20358456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1530891X20358456"],"URL":"https:\/\/doi.org\/10.4158\/ep171761.ra","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biotin Interference with Routine Clinical Immunoassays: Understand the Causes and Mitigate the Risks","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP171761.RA","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}